glp-1 news nov 2025 Coverage for some popular medications is set to go away in January GLP-1 Receptor Agonist Market Size

Exploring glucagon-like peptide-1 receptor agonists as potential disease-modifying agent in psychiatric and neurodevelopmental conditions: evidence from a drug target Mendelian randomization

Liraglutide, a glucagon-like peptide 1 receptor agonist, exerts analgesic, anti-inflammatory and anti-degradative actions in osteoarthritis

This can permanently alter the folding of the Retatrutide molecule, rendering it unable to properly engage the glucagon receptor

Eli Lilly is also developing oral GLP-1 receptor agonists, including compounds such as orforglipron, which have shown significant weight loss and glycemic improvements in Phase III clinical trials

Use measurements and progress photos to assess what the scale cannot

The current landing page's "fast weight loss" framing is more aggressive than the brand's earlier, more measured public materials